You are here
Clinical Trials: Heart Attack
Each Clinical Trial will open in a new browser window or tab.
Conditions: Diabetes Mellitus; Ischemic Heart Disease
Interventions: Drug: 100 million Allogeneic Mesenchymal Human Stem Cells; Other: Placebo
Sponsors: Joshua M Hare; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Interventions: Drug: 100 million Allogeneic Mesenchymal Human Stem Cells; Other: Placebo
Sponsors: Joshua M Hare; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Conditions: Myocardial Infarction; Heart Diseases
Intervention: Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Intervention: Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Condition: Coronary Artery Disease
Intervention: Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors: Navy General Hospital, Beijing; Chinese PLA General Hospital; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital
Not yet recruiting
Intervention: Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors: Navy General Hospital, Beijing; Chinese PLA General Hospital; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital
Not yet recruiting
Condition: Acute Myocardial Infarction
Interventions: Biological: Intravenous infusion placebo; Biological: Intravenous infusion WJMSCs
Sponsors: Navy General Hospital, Beijing; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital; Chinese PLA General Hospital
Not yet recruiting
Interventions: Biological: Intravenous infusion placebo; Biological: Intravenous infusion WJMSCs
Sponsors: Navy General Hospital, Beijing; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital; Chinese PLA General Hospital
Not yet recruiting
Condition: Severe COVID-19 Disease
Interventions: Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19; Other: Placebo
Sponsors: Rapa Therapeutics LLC; Hackensack Meridian Health
Not yet recruiting
Interventions: Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19; Other: Placebo
Sponsors: Rapa Therapeutics LLC; Hackensack Meridian Health
Not yet recruiting
Condition: Ischemia Reperfusion Injury
Intervention: Drug: Allogeneic adipose derived mesenchymal stem cells
Sponsor: Tambi Jarmi
Not yet recruiting
Intervention: Drug: Allogeneic adipose derived mesenchymal stem cells
Sponsor: Tambi Jarmi
Not yet recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Mesenchymal Stem Cells
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Intervention: Biological: Mesenchymal Stem Cells
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Condition: Heart Attack
Intervention: Drug: PEP in Acute Myocardial Infarction
Sponsor: Paul G. Stalboerger
Not yet recruiting
Intervention: Drug: PEP in Acute Myocardial Infarction
Sponsor: Paul G. Stalboerger
Not yet recruiting
Condition: Critical Limb Ischemia
Interventions: Drug: Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months.; Other: Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months
Sponsors: Leonardo Clavijo; Amgen
Recruiting
Interventions: Drug: Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months.; Other: Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months
Sponsors: Leonardo Clavijo; Amgen
Recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Recruiting
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Recruiting
